Global burden of thrombosis: epidemiologic aspects
AM Wendelboe, GE Raskob - Circulation research, 2016 - Am Heart Assoc
Thromboembolic conditions were estimated to account for 1 in 4 deaths worldwide in 2010
and are the leading cause of mortality. Thromboembolic conditions are divided into arterial …
and are the leading cause of mortality. Thromboembolic conditions are divided into arterial …
Epidemiology of stroke and transient ischemic attacks: Current knowledge and perspectives
Y Béjot, B Daubail, M Giroud - Revue neurologique, 2016 - Elsevier
Because of the growing size and aging of the world's population, the global burden of stroke
is increasing dramatically. Current epidemiological data indicate that 16.9 million people …
is increasing dramatically. Current epidemiological data indicate that 16.9 million people …
[HTML][HTML] Stroke: a global response is needed
W Johnson, O Onuma, M Owolabi… - Bulletin of the World …, 2016 - ncbi.nlm.nih.gov
Stroke: a global response is needed - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …
Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Background The contribution of modifiable risk factors to the increasing global and regional
burden of stroke is unclear, but knowledge about this contribution is crucial for informing …
burden of stroke is unclear, but knowledge about this contribution is crucial for informing …
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett… - circulation, 2016 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …
for Disease Control and Prevention, the National Institutes of Health, and other government …
Epidemiology of stroke in Europe and trends for the 21st century
Y Béjot, H Bailly, J Durier, M Giroud - La Presse Médicale, 2016 - Elsevier
Despite major improvements in primary prevention and acute treatment over the last
decades, stroke is still a devastating disease. At the beginning of the 21st century, the age …
decades, stroke is still a devastating disease. At the beginning of the 21st century, the age …
Efficacy and safety of non-immersive virtual reality exercising in stroke rehabilitation (EVREST): a randomised, multicentre, single-blind, controlled trial
G Saposnik, LG Cohen, M Mamdani… - The Lancet …, 2016 - thelancet.com
Background Non-immersive virtual reality is an emerging strategy to enhance motor
performance for stroke rehabilitation. There has been rapid adoption of non-immersive …
performance for stroke rehabilitation. There has been rapid adoption of non-immersive …
Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study
D Kalladka, J Sinden, K Pollock, C Haig, J McLean… - The Lancet, 2016 - thelancet.com
Background CTX0E03 is an immortalised human neural stem-cell line from which a drug
product (CTX-DP) was developed for allogeneic therapy. Dose-dependent improvement in …
product (CTX-DP) was developed for allogeneic therapy. Dose-dependent improvement in …
Patient outcomes up to 15 years after stroke: survival, disability, quality of life, cognition and mental health
Background The global epidemiological shift of disease burden towards long-term
conditions means understanding long-term outcomes of cardiovascular disease is …
conditions means understanding long-term outcomes of cardiovascular disease is …
Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF–TIMI 48 trial
ET Kato, RP Giugliano, CT Ruff… - Journal of the …, 2016 - Am Heart Assoc
Background Elderly patients with atrial fibrillation are at higher risk of both ischemic and
bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE …
bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE …